Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.

Brunner HI;Ruperto N;Zuber Z;Keane C;Harari O;Kenwright A;Lu P;Cuttica R;Keltsev V;Xavier RM;Calvo I;Nikishina I;Rubio Pérez N;Alexeeva E;Chasnyk V;Horneff G;Opoka Winiarska V;Quartier P;Silva CA;Silverman E;Spindler A;Baildam E;Gámir ML;Martin A;Rietschel C;Siri D;Smolewska E;Lovell D;MARTINI, ALBERTO;De Benedetti F;for the Paediatric Rheumatology International Trials Organisation;the Pediatric Rheumatology Collaborative Study Group

2014-01-01